Mental health problems like depression, anxiety, and eating disorders are becoming more common in the U.S. This puts pressure on healthcare systems. Many people with these issues do not get the treatment they need in time.
In one study, about 75% of people using an AI mental health chatbot were not getting medicine or therapy when they started. This shows a big gap in care. Without help, symptoms can get worse, and emergency and outpatient services can become overloaded.
Traditional therapy needs scheduled visits. Providers are not always available. Some patients feel uncomfortable sharing personal thoughts face-to-face. These problems make it harder for patients to take part in treatment and get the care they need.
Therabot is an AI therapy chatbot made by the Geisel School of Medicine and Dartmouth Health. It shows how technology can help with these problems. Therabot uses AI that can have natural and open conversations based on cognitive behavioral therapy (CBT).
People use Therabot through a phone app. This lets them get support anytime and anywhere. The chatbot works 24/7, which helps when mental health issues happen outside office hours, like in the middle of the night.
In an eight-week study with 106 participants, users spent an average of six hours with the chatbot. That is about the same as eight therapy visits. The AI gave real-time advice to cope that fit each person’s situation. Patients could talk about their worries and get quick help.
The study showed clear symptom improvements for several mental health problems:
These results were better than those in a control group. And most people were not using medicine or going to therapy during the study. The symptom drops were confirmed by clinical standards. This means AI therapy can help people feel better.
These results suggest that AI apps can work together with traditional therapy. They can also help more people get support and have frequent contact with providers. This is important in places where mental health professionals are not enough.
Some people think digital therapy tools lack emotional connection. But feedback from Therabot users shows otherwise. Many said they felt close to the chatbot. They described the relationship as similar to having a human therapist.
Nicholas Jacobson, a lead researcher of the study, said many patients treated the chatbot like a friend. The chatbot gave a safe, non-judgmental space. Patients could share their feelings without fear of being judged or criticized.
This kind of patient involvement is important for good mental health care. It helps people keep talking and sharing feelings, which is needed for therapy progress. The AI’s ability to have open conversations that fit each user’s needs helped build this connection.
Despite positive results, the chatbot should not work alone without clinician supervision. Mental health needs can be complicated and risky, especially with thoughts of suicide or other dangerous actions.
Therabot has features that detect warning signs and can send instant alerts to contact emergency services if needed. Mental health professionals in the study controlled safety rules and responses.
Michael Heinz, a co-author, said keeping clinicians involved is very important. Making sure AI responses match therapy standards and reduce harm needs ongoing checking and review.
For medical administrators and IT managers, AI chatbots offer more than clinical help. They improve work efficiency too. Adding AI mental health support to daily practice can ease work for front-office staff. It can automate simple patient tasks like appointment reminders, initial screenings, and urgent case triage.
Simbo AI is a company that shows how AI can smooth phone and communication tasks in healthcare. Automating calls and patient contact lets staff focus on more complex jobs while keeping patient contact steady.
Because AI chatbots work all day and night, patients get fast replies no matter clinic hours. This speeds up help and reduces missed appointments. AI also collects patient information during chats. This helps doctors make better decisions when they see the patients.
Automation helps follow healthcare rules and improves record-keeping. Patient talks are digitally saved and reported. This lowers mistakes and makes sure important details are ready for future care.
Medical offices in the U.S. with mental health patients can gain a lot by using AI chatbots:
These factors help improve patient satisfaction, treatment results, and work performance. They match what healthcare leaders and IT staff want for safe and expandable care technology.
While Dartmouth’s AI chatbot study shows positive results, there are more challenges before AI chatbots become common in U.S. medical offices.
Future work needs to focus on:
Healthcare leaders must carefully weigh costs and benefits. They also need to make sure AI tools have proper regulatory checks and clinical supervision.
AI mental health chatbots, running all the time on mobile apps, provide another kind of support that can make care easier to get and better in the United States. Medical staff and IT teams need to understand how these tools affect patient contact, therapy quality, and work processes. This helps them make good choices about adding AI to mental health care.
By using AI tools like Therabot and cooperating with companies such as Simbo AI, healthcare providers can improve the way mental health care is given. This can make services more responsive, effective, and focused on patients’ needs.
Therabot is a generative AI-powered therapy chatbot designed to provide mental health support. The clinical trial showed significant symptom improvement: a 51% reduction in depression symptoms, 31% in anxiety, and 19% in eating disorder concerns, suggesting AI-assisted therapy can have clinically meaningful benefits comparable to traditional outpatient therapy.
Participants engaged with Therabot through a smartphone app by typing responses or initiating conversations about their feelings. The AI provided personalized, open-ended dialogue based on therapeutic best practices, enabling continuous, real-time support tailored to users’ mental health needs.
The trial focused on individuals diagnosed with major depressive disorder, generalized anxiety disorder, and eating disorders. These conditions were selected due to their prevalence and varying treatment challenges, with Therabot showing differential but significant symptom reductions across these diagnoses.
Therabot detects high-risk content during conversations and responds by prompting users to call emergency services or suicide prevention hotlines with easy access buttons. The system operates under the supervision of clinicians who can intervene if necessary to ensure patient safety.
Clinician oversight is critical to monitor AI responses, manage risks, and intervene in high-risk situations. While AI can offer immediate support, supervised deployment ensures safety, efficacy, and adherence to therapeutic best practices, preventing potential harms from autonomous AI operation in mental health.
Therapeutic alliance refers to the trust and collaboration between a patient and caregiver. The study found users formed a bond with Therabot similar to that with human therapists, reflected in frequent engagement and detailed personal disclosure, essential for successful therapy outcomes.
Therabot offers 24/7 availability beyond office hours, empowering patients to access support whenever needed. Its mobile format allows users to engage anywhere, facilitating continuous care and immediate coping strategies for real-life challenges, addressing provider shortages and access barriers.
AI therapy agents must meet rigorous standards that ensure responses align with evidence-based practices, maintain appropriate tone, and protect users from harmful advice. Continuous evaluation and clinical involvement are essential to address risks and validate therapeutic outcomes before widespread use.
No AI therapy agent is ready for fully autonomous operation due to risks in complex, high-risk scenarios. Future work requires better understanding of these risks, enhanced safety controls, integration with clinical care, and improved AI capabilities to ensure effective, safe mental health interventions.
Therabot users engaged for around six hours, equivalent to eight therapy sessions, achieving symptom reductions on par with gold-standard cognitive therapy. Patients reported high levels of trust and ongoing engagement, indicating that AI can complement person-to-person therapy effectively.